Antifungal susceptibilities of the species of the Pseudallescheria boydii complex

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 4211-4213

  Gilgado, Fèlk ^a   Serena, Carolina ^a   Cano, Josep ^a   Gené, Josepa ^a   Guarro, Josep ^a,b  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; DILUTION; DRUG SENSITIVITY; FUNGUS ISOLATION; MICRODILUTION; NONHUMAN; PETRIELLIDIUM BOYDII; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM AURANTIACUM; SPECIES IDENTIFICATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; KETOCONAZOLE; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PEPTIDES, CYCLIC; PSEUDALLESCHERIA; PYRIMIDINES; QUALITY CONTROL; QUINAZOLINES; SCEDOSPORIUM; THIAZOLES; TRIAZOLES;

EID: 33845236150     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00981-06     Document Type: Article

References (18)

1. Apostolova, L. G., E. K. Johnson, and J. P. Adams. 2005. Disseminated Pseudallescheria boydii infection successfully treated with voriconazole. J. Neurol. Neurosurg. Psychiatry 76:1741-1742.
2. Balajee, S. A., J. L. Gribskov, E. Hanley, D. Nickle, and K. A. Marr. 2005. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot. Cell 4:625-632.
3. Capilla, J., and J. Guarro. 2004. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob. Agents Chemother. 48:4009-4011.
4. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in the treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
5. Carrillo, A. J., and J. Guarro. 2001. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob. Agents Chemother. 45:2151-2153.
6. Cuenca-Estrella, M., B. Ruiz-Diez, J. V. Martinez-Suarez, A. Monzon, and J. L. Rodriguez-Tudela. 1999. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J. Antimicrob. Chemother. 43:149-151.
7. Gilgado, F., J. Cano, J. Gené, and J. Guarro. 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942.
8. Guarro, J., A. S. Kantarcioglu, R. Horre, J. L. Rodriguez-Tudela, M. Cuenca-Estrella, J. Berenguer, and S. de Hoog. 2006. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med. Mycol. 44:295-327.
9. Kowacs, P. A., C. E. Soares-Silvado, S. Monteiro, M. Ramos, K. Abrao, L. E. Madaloso, R. L. Pinheiro, and L. C. Werneck. 2006. Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J. Clin. Pathol. 57:205-207.
10. Mellinghoff, I. K., D. J. Winston, G. Mukwaya, and G. J. Schiller. 2002. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin. Infect. Dis. 34:1648-1650.
11. National Committee for Clinical Laboratory Standards. 2002. References method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Pfaller, M. A., P. G. Pappas, and J. R. Wingard. 2006. Invasive fungal pathogens: current epidemiologicaf trends. Clin. Infect. Dis. 43:S3-S14.
13. Porte, L., L. El Hajj, S. Cassaing, A. Berry, P. Massip, M. D. Linas, J. F. Magnaval, N. Sans, and B. Marchou. 2006. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans. R. Soc. Trop. Med. Hyg. 100:891-894.
14. Pujol, C., M. A. Pfaller, and D. R. Soll. 2004. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob. Agents Chemother. 48:262-266.
15. Symoens, F., C. Knoop, M. Schrooyen, O. Denis, M. Estenne, N. Nolard, and F. Jacobs. 2006. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J. Heart Lung Transplant. 25:603-607.
16. Taylor, J. W., D. J. Jacobson, S. Kroken, T. Kasuga, D. M. Geiser, D. S. Hibbett, and M. C. Fisher. 2000. Phylogenetic species recognition and species concepts in fungi. Fungal Genet. Biol. 31:21-32.
17. Walsh, T. J., J. Peter, D. A. McGough, A. W. Fothergill, M. G. Rinaldi, and P. A. Pizzo. 1995. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob. Agents Chemother. 39:1361-1364.
18. Yustes, C., and J. Guarro. 2005. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob. Agents Chemother. 49:3498-3500.